This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2nm1

From Proteopedia

Revision as of 10:40, 21 November 2007 by OCA (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search

2nm1, resolution 2.15Å

Drag the structure with the mouse to rotate

Structure of BoNT/B in complex with its protein receptor

Overview

Botulinum neurotoxins (BoNTs) are produced by Clostridium botulinum and, cause the neuroparalytic syndrome of botulism. With a lethal dose of 1 ng, kg(-1), they pose a biological hazard to humans and a serious potential, bioweapon threat. BoNTs bind with high specificity at neuromuscular, junctions and they impair exocytosis of synaptic vesicles containing, acetylcholine through specific proteolysis of SNAREs (soluble, N-ethylmaleimide-sensitive fusion protein attachment protein receptors), which constitute part of the synaptic vesicle fusion machinery. The, molecular details of the toxin-cell recognition have been elusive. Here we, report the structure of a BoNT in complex with its protein receptor: the, receptor-binding domain of botulinum neurotoxin serotype B (BoNT/B) bound, to the luminal domain of synaptotagmin II, determined at 2.15 A, resolution. On binding, a helix is induced in the luminal domain which, binds to a saddle-shaped crevice on a distal tip of BoNT/B. This crevice, is adjacent to the non-overlapping ganglioside-binding site of BoNT/B., Synaptotagmin II interacts with BoNT/B with nanomolar affinity, at both, neutral and acidic endosomal pH. Biochemical and neuronal ex vivo studies, of structure-based mutations indicate high specificity and affinity of the, interaction, and high selectivity of BoNT/B among synaptotagmin I and II, isoforms. Synergistic binding of both synaptotagmin and ganglioside, imposes geometric restrictions on the initiation of BoNT/B translocation, after endocytosis. Our results provide the basis for the rational, development of preventive vaccines or inhibitors against these, neurotoxins.

About this Structure

2NM1 is a Single protein structure of sequence from Clostridium botulinum and Rattus norvegicus. Active as Bontoxilysin, with EC number 3.4.24.69 Full crystallographic information is available from OCA.

Reference

Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity., Jin R, Rummel A, Binz T, Brunger AT, Nature. 2006 Dec 21;444(7122):1092-5. Epub 2006 Dec 13. PMID:17167421

Page seeded by OCA on Wed Nov 21 12:47:38 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools